| Outgoing Relation(s) |
| EC 3.6.3.10 (H+/K+-exchanging ATPase) inhibitor (CHEBI:49200) is a EC 3.6.3.* (acid anhydride hydrolase catalysing transmembrane movement of substances) inhibitor (CHEBI:76895) |
| Incoming Relation(s) |
| bafilomycin A1 (CHEBI:22689) has role EC 3.6.3.10 (H+/K+-exchanging ATPase) inhibitor (CHEBI:49200) |
| diethylstilbestrol (CHEBI:41922) has role EC 3.6.3.10 (H+/K+-exchanging ATPase) inhibitor (CHEBI:49200) |
| esomeprazole (CHEBI:50275) has role EC 3.6.3.10 (H+/K+-exchanging ATPase) inhibitor (CHEBI:49200) |
| esomeprazole magnesium (CHEBI:50309) has role EC 3.6.3.10 (H+/K+-exchanging ATPase) inhibitor (CHEBI:49200) |
| lansoprazole (CHEBI:6375) has role EC 3.6.3.10 (H+/K+-exchanging ATPase) inhibitor (CHEBI:49200) |
| omeprazole (CHEBI:7772) has role EC 3.6.3.10 (H+/K+-exchanging ATPase) inhibitor (CHEBI:49200) |
| optochin (CHEBI:86455) has role EC 3.6.3.10 (H+/K+-exchanging ATPase) inhibitor (CHEBI:49200) |
| ouabain (CHEBI:472805) has role EC 3.6.3.10 (H+/K+-exchanging ATPase) inhibitor (CHEBI:49200) |
| pantoprazole (CHEBI:7915) has role EC 3.6.3.10 (H+/K+-exchanging ATPase) inhibitor (CHEBI:49200) |
| pantoprazole sodium (CHEBI:50270) has role EC 3.6.3.10 (H+/K+-exchanging ATPase) inhibitor (CHEBI:49200) |
| rabeprazole (CHEBI:8768) has role EC 3.6.3.10 (H+/K+-exchanging ATPase) inhibitor (CHEBI:49200) |
